| 研究実績の概要 |
In the past fiscal year, efforts were focused on establishing a method to robustly generate functional hematopoietic stem cells (HSC) from the peripheral blood of donor mice. Our protocol allows for 4 to 5-fold expansion of harvested peripheral blood-derived stem cells after about one week. These cells could be gene edited using the CRISPR/Cas9 system, generating enough cells for stable engraftment in a autologous transplant setting. Furthermore, we were able to publish our HSC gene editing system which enables the production of a large number of genetically modified, transplantable stem cells from a single cell clone. Our findings published in this report will greatly contribute to applying the intrauterine transplantation approach to the SCID model, as outlined in the research plan.
|
| 現在までの達成度 (区分) |
現在までの達成度 (区分)
2: おおむね順調に進展している
理由
Since the laboratory of the applicant has moved to a new institution, and due to subsequent short-term lack of appropriate equipment, the intrauterine transplantaion experiments could not be carried out as initlally planned. Furthermore, clinical responsibilities of the applicant has interfered with some time-consuming experiments.
|
